gimli

BPLPHARMA stock AI analysis

BPLPHARMA Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

BHARAT PARENTERALS LTD. is a small-cap stock in Healthcare. This Gimli page shows the latest available BPLPHARMA price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive BPLPHARMA stock page

Price

₹1,864.00

1W return

+8.35%

1M return

+22.74%

3M return

n/a

6M return

n/a

1Y return

n/a

Market cap

₹n/a

n/a

ROE

-2.79%

ROCE

-1.82%

RSI

60.60

Turnover

₹1.89 cr

Why it can matter in screens

Momentum: BPLPHARMA is below 50DMA, below 200DMA; RSI is 60.60.
Returns: 1D -1.52%, 1W +8.35%, 1M +22.74%, 3M n/a, 1Y n/a.
Trend levels: 52W high ₹2,277.60, 52W low ₹1,125.70, off high -18.16%.
Liquidity: latest turnover is ₹1.89 cr; volume vs 20D is +0.57%.
Valuation/profitability: PE n/a, PB n/a, ROE -2.79%, ROCE -1.82%.
Growth: 3Y sales CAGR +16.39%, 3Y profit CAGR n/a.

Quick Answers

What is the latest BPLPHARMA stock price?

The latest stored price for BPLPHARMA is Rs 1,864.00 as of 2026-10-09.

Is BPLPHARMA above its 50DMA and 200DMA?

BPLPHARMA is below 50DMA, below 200DMA. The latest 50DMA is n/a and the latest 200DMA is n/a.

What are BPLPHARMA PE, ROE and ROCE?

BPLPHARMA has PE n/a, ROE -2.79%, and ROCE -1.82% in Gimli's latest available snapshot.

How has BPLPHARMA performed recently?

BPLPHARMA has returned +22.74% over 1 month, n/a over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	99.62 cr	3.10 cr	-4.80 cr	n/a
2025-12-31	65.19 cr	3.07 cr	-5.28 cr	n/a
2025-09-30	64.62 cr	4.36 cr	-7.24 cr	n/a
2025-06-30	116.00 cr	14.84 cr	8.23 cr	n/a
2025-03-31	103.98 cr	4.16 cr	-4.73 cr	n/a

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	343.05 cr	24.29 cr	-8.19 cr	-39.62
2025-03-31	335.48 cr	13.29 cr	-12.63 cr	-66.64
2024-03-31	257.05 cr	30.92 cr	14.52 cr	24.94
2023-03-31	217.56 cr	31.62 cr	16.44 cr	28.40
2022-03-31	n/a	n/a	n/a	nan

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	613.30 cr	1.48 cr	146.11 cr	311.58 cr
2025-03-31	648.53 cr	0.56 cr	180.20 cr	339.00 cr
2024-03-31	504.04 cr	8.71 cr	157.58 cr	238.17 cr
2023-03-31	350.34 cr	7.85 cr	49.74 cr	217.90 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	38.36 cr	-1.57 cr	n/a
2025-03-31	-27.25 cr	-56.33 cr	n/a
2024-03-31	-4.71 cr	-109.01 cr	n/a
2023-03-31	21.66 cr	-69.94 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	422,282.96 cr	34.857273	+15.50%	+6.12%
DIVISLAB	DIVI S LABORATORIES LTD	247,947.67 cr	85.088426	+18.37%	+52.32%
TORNTPHARM	TORRENT PHARMACEUTICALS L	157,610.64 cr	72.265309	+17.33%	+31.16%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	115,423.17 cr	58.937484	+21.03%	+4.32%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	112,446.65 cr	25.058308	+16.04%	+12.37%
LAURUSLABS	LAURUS LABS LIMITED	109,947.20 cr	100.670416	+21.77%	+135.42%
CIPLA	CIPLA LTD	105,094.85 cr	31.162389	+10.25%	-14.02%
DRREDDY	DR. REDDY S LABORATORIES	99,661.60 cr	30.096514	+9.23%	-3.94%

Try these prompts

Analyze BHARAT PARENTERALS. with valuation, momentum and industry peers
Compare BPLPHARMA with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-10-09. Not investment advice.